Home / Intelligence / Webinars / The Future of Patient Finding
Available On Demand
Patient finding is more than a buzzword. Ready to challenge the status quo?
With more data, advancements in AIML and greater access to insights, it is not surprising that patient finding is evolving. Many pharma organizations have deep-rooted ideas about what patient finding requires, but they often miss the opportunity to put the patient at the center.
Join Trinity Life Sciences’ experts as we debunk common misconceptions and discuss the actionable potential of patient finding throughout the drug development lifecycle. We will share real-world use cases to show how the insights and analytics derived from patient finding studies can power patient engagement strategies today and beyond.
Key Webinar Topics
- Discuss the evolution of patient finding and challenge common beliefs
- Review real-world use cases of patient finding analyses across the journey continuum
- Consider and explore the future of patient finding through expansion of additional data sources and approaches
Featuring
Steven Laux
Vice President, Analytics &
Head of Generative AI
Sri Saikumar
Principal,
Real World Evidence
Complete the form below to view the on-demand webinar.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
*Gartner, Hype Cycle for Life Sciences Commercial Operations, Animesh Gandhi, published 13 August 2024.
GARTNER is a registered trademark and service mark of Gartner and Hype Cycle is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Related Intelligence
Webinars
The GenAI Advantage: Empowering Pharma Customer-Facing Teams
June 11, 2025 | 1:00 – 1:45 PM ET
Additional sessions will be offered on:June 12 – 12:00 (UTC +8:00) – Asia/ShanghaiJune 12 – 12:00 CET – Europe/Berlin Join us for the first webinar in our “AI Innovations in Life Sciences” series to learn how generative AI (GenAI) can transform the way customer-facing teams (sales reps and medical science liaisons) operate in life sciences […]
Sign Up Now
White Papers
Technology with a Point of View: Encoding Life Sciences Expertise with AI
As an industry, life sciences is now looking towards technological change to leverage investments made during the past few years. In fact, according to Trinity’s TGaS Advisors, the proportion of surveyed companies reporting that they have completed proof of concept or are using GenAI at an enterprise level for commercial, medical, or customer operations surged […]
Read More
Blog
Operationalizing Generative AI in Life Sciences—Trinity Life Sciences Included in Everest Group Report
The transformative potential of generative AI (GenAI) within the life sciences industry is highlighted in Everest Group’s report, “AI-deas to Action: Operationalizing Generative AI in Life Sciences.” Fifteen companies were selected for inclusion across three categories: To be included in the report, providers had to have been profiled in past Everest Group PEAK Matrix® […]
Read More